Clinical Trial Update: Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study) [Phase 4]

View source ↗

Summary

Phase 4 trial update on dose optimization for safe and efficient fluorescein angiography in retinal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Disease

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Retinal Disease | Phase 4 | Status: COMPLETED